• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    cbdMD Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    5/7/25 4:03:23 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $YCBD alert in real time by email
    ycbd20250506_8k.htm
    false 0001644903 0001644903 2025-05-06 2025-05-06 0001644903 ycbd:CommonCustomMember 2025-05-06 2025-05-06 0001644903 ycbd:SeriesACumulativeConvertiblePreferredStock8CustomMember 2025-05-06 2025-05-06

    --09-30
     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
     
    FORM 8-K
     
    CURRENT REPORT
     
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
     
    Date of Report (Date of earliest event reported) May 6, 2025
     
    image6.jpg
     
    cbdMD, INC.
    (Exact name of registrant as specified in its charter)
     
    North Carolina
    001-38299
    47-3414576
    (State or other jurisdiction of incorporation or organization)
    (Commission File Number)
    (I.R.S. Employer Identification No.)
     
    2101 Westinghouse Blvd., Suite A, Charlotte, NC 28273
    (Address of principal executive offices)(Zip Code)
     
    Registrant's telephone number, including area code: (704) 445-3060
     
     

    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
     
    Securities registered pursuant to Section 12(b) of the Act:
     
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    common
    YCBD
    NYSE American
    8% Series A Cumulative Convertible Preferred Stock
    YCBD PR A
    NYSE American
     
    Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
     
    Emerging growth company ☐
     
    If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
     
     

     
     
    Item 3.03. Material Modification to Rights of Security Holders.
     
    The information contained in Item 5.03 below is incorporated by reference into this Item 3.03.
     
    Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
     
    Effective May 6, 2025, the Company filed an Articles of Amendment to its the Certificate of Designation of Rights and Preferences 8.0% Series A Cumulative Convertible Preferred Stock (the “Automatic Preferred Conversion Articles of Amendment”) with the Secretary of State of the State of North Carolina effective 4:01 p.m. Eastern Time on May 6, 2025 (the “Mandatory Exchange Date”). Pursuant to the Automatic Preferred Conversion Articles of Amendment each outstanding share of the Company’s 8% Series A Cumulative Convertible Preferred Stock (the “Preferred Stock”) automatically, without any action on the part of the Preferred Stock holder, converts into thirteen shares of the Company’s Common Stock (the “Automatic Conversion”). The Automatic Conversion of the 5,000,000 issued and outstanding shares of Preferred Stock, inclusive of all accumulated and unpaid dividends, into 65,000,000 shares of Common Stock is effective on the Mandatory Exchange Date. The Company’s shareholders approved the Automatic Preferred Conversion Articles of Amendment on April 10, 2025 at the Company’s annual meeting of shareholders. Dividends on converted shares of Preferred Stock ceased to accrue on the Mandatory Exchange Date and the Preferred Stock ceased trading on the NYSE American LLC, on the Mandatory Exchange Date.
     
    In addition effective May 6, 2025 and immediately following the Mandatory Exchange Date, the Company filed an Articles of Amendment to the Company’s Articles of Incorporation, as amended (the “Reverse Split Articles of Amendment”), which effected, at 4:02 p.m. Eastern Time on May 6, 2025, a one-for-8 reverse stock split of the Company’s issued and outstanding shares of Common Stock (the “Reverse Stock Split”). At the Company’s annual meeting of shareholders held on April 10, 2025, the shareholders of the Company approved the Reverse Stock Split. In connection with the Reverse Stock Split, the CUSIP number for the Common Stock changed to 12482W 409. The Common Stock began trading on the NYSE American on a Reverse Stock Split-adjusted basis when market opened on May 7, 2025.
     
    As a result of the Reverse Stock Split, every 8 shares of Common Stock issued and outstanding (including the shares of Common Stock issued pursuant to the Automatic Conversion) were converted into one share of Common Stock. The Reverse Stock Split affected all shareholders uniformly and did not alter any shareholder’s percentage interest in the Company’s equity, except to the extent that the Reverse Stock Split would have result in some shareholders owning a fractional share. No fractional shares were issued in connection with the Reverse Stock Split. Shareholders who would otherwise be entitled to a fractional share of Common Stock are instead entitled to receive one whole share.
     
    The Reverse Stock Split did not change the par value of the Common Stock or the authorized number of shares of Common Stock. All outstanding securities entitling their holders to purchase shares of Common Stock or acquire shares of Common Stock, including stock options and warrants, were adjusted as a result of the Reverse Stock Split, as required by the terms of those securities.
     
    The foregoing description of the Automatic Preferred Conversion Articles of Amendment and Reverse Split Articles of Amendment is a summary of the material terms thereof, does not purpose to be complete and is qualified in its entirety by reference to the full text of the Automatic Preferred Conversion Articles of Amendment and Reverse Split Articles of Amendment, which are filed with this report as Exhibit 3.1 and Exhibit 3.2, respectively, and are incorporated hereby by reference.
     
    Item 9.01. Financial Statements and Exhibits.
     
    (d) Exhibits.
     
    Exhibit
    No.
     
       
    3.1
    Articles of Amendment to Articles of Incorporation Automatic Preferred Conversion effective May 6, 2025
    3.2
    Articles of Amendment to Articles of Incorporation Reverse Split effective May 6, 2025
    104
    Cover Page Interactive Data File (embedded within the Inline XBRL document).
     
    1

     
     
    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
     
    cbdMD, Inc.
         
    Date: May 7, 2025
    By:
    /s/ T. Ronan Kennedy
       
    T. Ronan Kennedy, Chief Executive Officer and Chief Financial Officer
     
    2
    Get the next $YCBD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $YCBD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $YCBD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald resumed coverage on cbdMD with a new price target

    Cantor Fitzgerald resumed coverage of cbdMD with a rating of Neutral and set a new price target of $3.25 from $4.10 previously

    6/18/21 6:26:36 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Cantor Fitzgerald reiterated coverage on cbdMD with a new price target

    Cantor Fitzgerald reiterated coverage of cbdMD with a rating of Neutral and set a new price target of $4.30 from $3.60 previously

    1/29/21 4:54:10 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    SEC Filings

    View All

    SEC Form 10-Q filed by cbdMD Inc.

    10-Q - cbdMD, Inc. (0001644903) (Filer)

    8/14/25 4:06:43 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD Inc. filed SEC Form 8-K: Other Events

    8-K - cbdMD, Inc. (0001644903) (Filer)

    5/20/25 5:19:59 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 10-Q filed by cbdMD Inc.

    10-Q - cbdMD, Inc. (0001644903) (Filer)

    5/15/25 4:07:09 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    cbdMD Generates $4.6 Million of Revenue for the 3rd Quarter

    Announces Oasis Expands into Multiple New StatesCharlotte, North Carolina--(Newsfile Corp. - August 14, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the third quarter of fiscal year ended September 30, 2025. The Company delivered $4.6 million in revenue for the third quarter, down from $5.2 million in the prior year period. Operating loss increased from $0.4 million to $0.9 million. "While our third quarter results were not up to our standard, we have completed a major overhaul to our marketing team and dig

    8/14/25 4:08:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD, Inc. to Host Conference Call to Discuss June 30, 2025, Third Quarter of Fiscal Year 2025 Results

    Charlotte, North Carolina--(Newsfile Corp. - August 12, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 14, 2025, to discuss the company's June 30, 2025 third quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, August 14, 2025, 4:20 p.m. Eastern Time   USA/Canada: 833-821-3524  International: 647-846-2919    Teleconference Replay dial in:   USA/Canada: 855-669-9658  International: 412-317-0088  Replay Passcode: 5327882  Webcast/Webcast Replay link - available through August 15, 20

    8/12/25 10:22:00 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD Expands Oasis Social Tonics to Total Wine

    Charlotte, North Carolina--(Newsfile Corp. - June 24, 2025) - cbdMD, Inc. (NYSE:YCBD), a trusted leader in the wellness and cannabinoid industry, is proud to announce the retail debut of its Herbal Oasis Social Tonics at select Total Wine in Charlotte and surrounding North Carolina areas. The premium line of hemp-derived THC seltzers, first launched in late 2024, is now available across Total Wine stores across North Carolina.With strong initial placement in the Charlotte metro, the company is signaling its commitment to expanding Oasis Social Tonics throughout the state. Designed for mindful socialization, Herbal Oasis Social Tonics combine hemp-derived THC and CBG with a nootropic blend of

    6/24/25 7:00:00 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    Financials

    Live finance-specific insights

    View All

    cbdMD Generates $4.6 Million of Revenue for the 3rd Quarter

    Announces Oasis Expands into Multiple New StatesCharlotte, North Carolina--(Newsfile Corp. - August 14, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the third quarter of fiscal year ended September 30, 2025. The Company delivered $4.6 million in revenue for the third quarter, down from $5.2 million in the prior year period. Operating loss increased from $0.4 million to $0.9 million. "While our third quarter results were not up to our standard, we have completed a major overhaul to our marketing team and dig

    8/14/25 4:08:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD, Inc. to Host Conference Call to Discuss June 30, 2025, Third Quarter of Fiscal Year 2025 Results

    Charlotte, North Carolina--(Newsfile Corp. - August 12, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Thursday, August 14, 2025, to discuss the company's June 30, 2025 third quarter of fiscal year 2025 financial results and business progress.CONFERENCE CALL DETAILSThursday, August 14, 2025, 4:20 p.m. Eastern Time   USA/Canada: 833-821-3524  International: 647-846-2919    Teleconference Replay dial in:   USA/Canada: 855-669-9658  International: 412-317-0088  Replay Passcode: 5327882  Webcast/Webcast Replay link - available through August 15, 20

    8/12/25 10:22:00 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD Delivers Continued Revenue Growth and Trend Towards Profitability in Second Fiscal Quarter

    Successfully Completes Capital Structure Reset with Series A Preferred ConversionCharlotte, North Carolina--(Newsfile Corp. - May 15, 2025) - cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, and Herbal Oasis today announced our financial results for the second quarter of fiscal year ended September 30, 2025. The Company reported continued year-over-year improvements in both revenue and earnings while completing a transformative restructuring of its capital structure.The Company delivered $4.8 million in revenue for the second quarter, up from $4.3 million in the prior year peri

    5/15/25 4:09:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    Leadership Updates

    Live Leadership Updates

    View All

    cbdMD, Inc. Announces Shareholder Approval of Automatic Conversion of Series A Preferred Stock and Other Results from Annual Meeting

    Charlotte, North Carolina--(Newsfile Corp. - April 10, 2025) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA) (the "Company" or "cbdMD") one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with its functional mushroom brand ATRx Labs and emerging THC-infused seltzer brand Herbal Oasis announced today that at the Company's annual meeting of shareholders held on April 10, 2025, that its Common Stock holders and 8% Series A Cumulative Convertible Preferred Stock (the "Preferred Stock") holders approved the automatic conversion (the "Conversion") of shares of the Company's Preferred Stock into shares of the Comp

    4/10/25 5:57:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD Announces Partnership with Medical Advisor, Dr. Lucille Vega

    Charlotte, North Carolina--(Newsfile Corp. - June 22, 2023) - cbdMD (NYSE:YCBD), one of the nation's leading providers of premium cannabidiol (CBD) products, is delighted to announce the appointment of Dr. Lucille Vega as their new medical advisor. This collaboration marks an exciting chapter for both parties, as they play a pivotal role in educating the public about the numerous benefits of CBD and cbdMD's commitment to quality and transparency.As a brand that's renowned for its commitment to quality and innovation, cbdMD's comprehensive line of products spans across various categories and caters to a diverse range of consumer needs. By partnering with Dr. Vega, a highly qualified and passi

    6/22/23 9:00:00 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    cbdMD Welcomes Shannon Charles as Chief Marketing Officer

    Charlotte, North Carolina--(Newsfile Corp. - January 11, 2023) - cbdMD, Inc. (NYSE:YCBD) (NYSE:YCBDPA), one of the nation's leading, highly trusted and widely recognized CBD companies, today announces the appointment of Shannon Charles as Chief Marketing Officer. Shannon is a veteran in health and wellness with over a decade of success in the Natural Product Industry. She has a proven record in driving growth across B&M retail, warehouse club stores, ecommerce, as well as international markets. Shannon's leadership has supported the successful brand stories of Naturade, NeoCell, and NutraNext, which the latter was ultimately acquired by The Clorox Co during her tenure. "We are thrilled to h

    1/11/23 12:33:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Porter Jeffrey H was granted 1,572 shares (SEC Form 4)

    4 - cbdMD, Inc. (0001644903) (Issuer)

    5/20/25 5:23:40 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Raines William F Iii was granted 1,572 shares, increasing direct ownership by 15% to 12,104 units (SEC Form 4)

    4 - cbdMD, Inc. (0001644903) (Issuer)

    5/20/25 5:23:18 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Roe Kevin Charles was granted 1,572 shares, increasing direct ownership by 7% to 25,135 units (SEC Form 4)

    4 - cbdMD, Inc. (0001644903) (Issuer)

    5/20/25 5:22:53 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $YCBD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

    SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

    8/12/22 4:02:14 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

    SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

    6/21/22 7:52:33 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13D/A filed by cbdMD Inc. (Amendment)

    SC 13D/A - cbdMD, Inc. (0001644903) (Subject)

    5/19/22 4:05:28 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary